657
Participants
Start Date
June 30, 2012
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
NVA237
NVA237 50 μg inhalation capsules once a day, delivered via SDDPI
Tiotropium
Tiotropium 18 μg once a day delivered via HandiHaler® device
Placebo to tiotropium
Placebo to tiotropium 18 μg o.d. once a day delivered via HandiHaler® device.
Placebo to NVA237
Placebo to NVA237 50 μg once a day delivered via SDDPI
salbutamol/albuterol
salbutamol/albuterol given as a rescue medication via inhaler when needed
Novartis Investigative Site, Chiayi City
Novartis Investigative Site, Manila
Novartis Investigative Site, Riga
Novartis Investigative Site, Quezon City
Novartis Investigative Site, Bulacan
Novartis Investigative Site, Lipa City
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Gatesville
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Zagreb
Novartis Investigative Site, Berlin
Novartis Investigative Site, Tallinn
Novartis Investigative Site, Tallinn
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Rüdersdorf
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Rudná
Novartis Investigative Site, Kassel
Novartis Investigative Site, Taichung
Novartis Investigative Site, Sisak
Novartis Investigative Site, Nantes
Novartis Investigative Site, Tartu
Novartis Investigative Site, Reims
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Beuvry
Novartis Investigative Site, Wiesbaden
Novartis Investigative Site, Lyon
Novartis Investigative Site, Paide
Novartis Investigative Site, Niaosong Township
Novartis Investigative Site, Klaipėda
Novartis Investigative Site, Coimbatore
Novartis Investigative Site, Toronto
Novartis Investigative Site, Toronto
Novartis Investigative Site, Toronto
Novartis Investigative Site, Gatineau
Novartis Investigative Site, Mirabel
Novartis Investigative Site, Saint-Charles-Borromée
Novartis Investigative Site, Zagreb
Novartis Investigative Site, Cvikov
Novartis Investigative Site, Liberec
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Teplice
Novartis Investigative Site, Žatec
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Guntur
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, Chennai - Tamil Nadu
Novartis Investigative Site, Bangalore
Novartis Investigative Site, Nagpur
Novartis Investigative Site, Bucheon-si
Novartis Investigative Site, Taipei County
Novartis Investigative Site, Chiayi City
Novartis Investigative Site, Coimbatore
Novartis Investigative Site, Daugavpils
Novartis Investigative Site, Alytus
Novartis Investigative Site, Kaunas
Novartis Investigative Site, Klaipėda
Novartis Investigative Site, Utena
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Katowice
Novartis Investigative Site, Poznan
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Busan
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Daegu
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY